Cleared Traditional

K884809 - DELFIA SHBG KIT

K884809 is an FDA 510(k) clearance for DELFIA SHBG KIT, manufactured by Pharmacia, Inc.. The device is a Class 1 Chemistry device with product code CDZ cleared through the Traditional 510(k) pathway after a 111-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1989
Decision
111d
Days
Class 1
Risk

K884809 is an FDA 510(k) clearance for the DELFIA SHBG KIT. Classified as Radioimmunoassay, Testosterones And Dihydrotestosterone (product code CDZ), Class I - General Controls.

Submitted by Pharmacia, Inc. (Piscataway, US). The FDA issued a Cleared decision on March 8, 1989 after a review of 111 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1680 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Pharmacia, Inc. devices

FDA 510(k) Submission Details - K884809

510(k) Number K884809 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 17, 1988
Decision Date March 08, 1989
Days to Decision 111 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
23d slower than avg
Panel avg: 88d · This submission: 111d
Pathway characteristics
Predicate-based equivalence.

CDZ Device Classification - Class 1, General Controls

Product Code CDZ Radioimmunoassay, Testosterones And Dihydrotestosterone
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1680
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CDZ Radioimmunoassay, Testosterones And Dihydrotestosterone

All 68
Devices cleared under the same product code (CDZ) and FDA review panel - the closest regulatory comparables to K884809.
GAMMA COAT ASSAY TESTOSTERONE RADIOIMMUNOASSAY KIT
K915570 · Incstar Corp. · Jan 1992
SHBG IRMA KIT
K905247 · Ventrex Laboratories, Inc. · Jan 1991
DSL SEX HORMONE BINDING GLOBULIN (SHBG) (DSL 6300)
K904100 · Diagnostic Systems Laboratories, Inc. · Oct 1990
IRMA-COUNT (TM) SHBG (SEX HORMORNE BIND GLOBULIN)
K883267 · Diagnostic Products Corp. · Oct 1988
LEECO TESTOSTERONE DIAGNOSTIC KIT
K860003 · Leeco Diagnostics, Inc. · Mar 1986
DSL ACTIVE TESTOSTERONE RIA (DSL #4000)
K854671 · Diagnostic Systems Laboratories, Inc. · Dec 1985